ArticleNPJ digital medicine2025
Personalized and real time hemodynamic management in critical care using Dynamic Cohort Ensemble Learning (DynaCEL).
Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Effects of aromatherapy on objective physiological outcomes in adult ICU patients: a systematic review.Frontiers in medicine · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Effective hemodynamic management in the intensive care unit requires individualized targets that adapt to dynamic clinical conditions. We developed Dynamic Cohort Ensemble Learning (DynaCEL), a real-time framework that recommends personalized heart rate and systolic blood pressure targets by modeling each time point post-intensive care unit admission as a distinct temporal cohort. Trained on eICU data and validated on MIMIC-IV and Indiana University Health datasets, DynaCEL demonstrated robust predictive performance (AUCs 0.83-0.91). In the MIMIC-IV cohort, proximity to DynaCEL-predicted targets was associated with lower 24-hour mortality compared to fixed targets, after adjustment using propensity score matching. Dose-response and comparative analyses revealed that greater deviations from personalized targets were associated with higher mortality. Case studies illustrated temporal and inter-individual variation in optimal targets. DynaCEL offers interpretable and scalable support for exploring precision hemodynamic management, although its clinical utility remains to be established in prospective trials.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.